Brian Abrahams
Analyst at RBC Capital
Ticker Coverage
Sector Coverage
Mentions in the News
Biogen, Eisai revive plans for Alzheimer's drug, surprising market
Biogen Inc revived plans on Tuesday to seek U.S. approval for Alzheimer's treatment aducanumab, surprising investors and saying data from more patients in two discontinued studies showed the drug reduced the decline of patients.
Published: Oct 23 2019
Alzheimer’s drug hopes see Biogen shares surge 27%
Pharma group resurrects pipeline therapy it abandoned as ineffective earlier this year
Published: Oct 22 2019
Biogen resurrects Alzheimer's drug; shares jump 27per cent
Biogen Inc is planning to file for U.S. regulatory approval for its Alzheimer's treatment aducanumab after fresh analysis of its clinical trial showed promise, the drugmaker said on Tuesday, sending its shares up 21per cent before the bell.
Published: Oct 22 2019
Show More..
Earnings Call Transcripts
Biogen Inc. (BIIB) CEO Michel Vounatsos on Q3 2019 Results - Earnings Call Transcript
Biogen Inc. (NASDAQ:BIIB) Q3 2019 Earnings Conference Call October 22, 2019 08:00 ET Company Participants Joe Mara - Vice President, Investor Relations Michel V
Published: Oct 22 2019
Biogen Inc (BIIB) Q3 2019 Earnings Call Transcript
BIIB earnings call for the period ending September 30, 2019.
Published: Oct 22 2019
Edited Transcript of TH.TO earnings conference call or presentation 8-Oct-19 12:30pm GMT
Q3 2019 Theratechnologies Inc Earnings Call
Published: Oct 10 2019
Show More..
Would you like to be included in the directory? Let us know!
© Street Contxt. All Rights Reserved.